A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

June 30, 1993

Study Completion Date

January 31, 2001

Conditions
Breast NeoplasmsFeverHematologic DiseasesNeutropeniaSepsis
Interventions
DRUG

FLAC chemotherapy with GM-CSF

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH